Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices 12207 

6, 10, 12, and 13 of the ’007 patent; and 

whether an industry in the United 

States exists as required by subsection 

(a)(2) of section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘robotic vacuums and 

wet/dry mops, their docking stations, 

and associated parts and components 

(including software)’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainant is: 

iRobot Corporation 

8 Crosby Drive 

Bedford, MA 01730 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

SharkNinja Operating LLC, 89 A St. 

#100, Needham, MA 02494 

SharkNinja Management LLC, 89 A St. 

#100, Needham, MA 02494 

SharkNinja Management Co., 89 A St. 

#100, Needham, MA 02494 

SharkNinja Sales Co., 89 A St. #100, 

Needham, MA 02494 

EP Midco LLC, 89 A St. #100, Needham, 

MA 02494 

SharkNinja Hong Kong Co. Ltd., 238 Des 

Voeux Road Central, Sheung Wan, 

Central & Western District—Hong 

Kong Island, Hong Kong 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party in this investigation. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainant of the 

complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: February 25, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–04294 Filed 3–1–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–801] 

Importer of Controlled Substances 

Application: Stepan Company 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Stepan Company has applied 

to be registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 1, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 1, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 08, 2021, 

Stepan Company, 100 West Hunter 

Avenue, Maywood, New Jersey 07607– 

1021, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled 

substance Drug Code Schedule 

Coca Leaves .... 9040 II 

The company plans to import the 

listed controlled substance in bulk for 

the manufacture of controlled 

substances for distribution to its 

customers. No other activity for this 

drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–04245 Filed 3–1–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Federal Bureau of Investigation 

[OMB Number 1110–0039] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Revision of a 

Currently Approved Collection 

Bioterrorism Preparedness Act: Entity/ 

Individual Information 

AGENCY: Federal Bureau of 

Investigation, Criminal Justice 

Information Services Division, 

Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Federal Bureau of Investigation 

(FBI), Criminal Justice Information 

Services (CJIS) Division will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

DATES: Comments are encouraged and 

will be accepted for 60 days until May 

3, 2021. 


jbell on DSKJLSW7X2PROD with NOTICES
12208 Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

James J. Sheets, Biometric Services 

Section, Identity Management Unit, 

Federal Bureau of Investigation, CJIS 

Division, Biometric Technology Center, 

1000 Custer Hollow Road, Clarksburg, 

West Virginia 26306. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. The Title of the Form/Collection: 

Federal Bureau of Investigation 

Bioterrorism Preparedness Act: Entity/ 

Individual Information. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

The form is FD–961. The applicable 

component within the Criminal Justice 

Information Services Division, 

Department of Justice (DOJ), Federal 

Bureau of Investigation (FBI). 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract:. 

Primary: City, country, state, federal, 

individuals, business or other for profit, 

and not-for-profit institute. This 

collection is needed to receive names 

and other identifying information 

submitted by individuals requesting 

access to specific agents or toxins, and 

consult with appropriate officials of the 

Department of Health and Human 

Services and the Department of 

Agriculture as to whether certain 

individuals specified in the provisions 

should be denied access to or granted 

limited access to specific agents. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: There are approximately 3,655 

(FY 2020) and respondents at 1 hour 30 

minutes for the FD–961 form. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated public burden 

associated with this collection is 

approximately 5,483 hours annual 

burden, associated with this information 

collection. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405A, 

Washington, DC 20530. 

Dated: February 24, 2021. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2021–04208 Filed 3–1–21; 8:45 am] 

BILLING CODE 4410–02–P 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

State All Payer Claims Databases 

Advisory Committee 

AGENCY: Employee Benefits Security 

Administration, Department of Labor. 

ACTION: Notice. 

SUMMARY: This notice announces the 

establishment of the State All Payer 

Claims Databases Advisory Committee 

(Committee) and also solicits 

nominations for members to be 

appointed by the Secretary of Labor 

(Secretary). The No Surprises Act, 

enacted as part of the Consolidated 

Appropriations Act, 2021, requires the 

Department of Labor (DOL) to establish 

(and periodically update) a standardized 

reporting format for voluntary reporting 

by group health plans to State All Payer 

Claims Databases and provide guidance 

to States on collecting data. The Act also 

directs the Secretary to convene an 

advisory committee. 

DATES: Nominations for membership 

will be considered if they are received 

by March 16, 2021. 

ADDRESSES: Send nominations to 

SAPCDACnominations@dol.gov to the 

attention of Elizabeth Schumacher, 

Office of Health Plan Standards and 

Compliance Assistance, Employee 

Benefits Security Administration, DOL. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Schumacher, Employee 

Benefits Security Administration, DOL 

at 202–693–8335. For press inquiries 

contact Grant Vaught, Office of Public 

Affairs, DOL at 202–693–4672. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 735 of the Employee 

Retirement Income Security Act of 1974, 

as added by section 115(b) of the No 

Surprises Act, enacted as part of the 

Consolidated Appropriations Act, 2021, 

div. BB, tit. I, Public Law 116–260 (Dec. 

27, 2020), requires the DOL to establish 

(and periodically update) a standardized 

reporting format for voluntary reporting 

by group health plans to State All Payer 

Claims Databases and provide guidance 

to States on collecting data. The Act also 

directs the Secretary to convene an 

advisory committee consisting of no 

more than 15 members to advise the 

Secretary regarding the format and 

guidance for voluntary reporting by 

group health plans to State All Payer 

Claims Databases. The Committee will 

remain in existence from the time of its 

convention until it submits its report 

with its recommendations to the 

Secretary, the Committee on Health, 

Education, Labor, and Pensions of the 

Senate, and the Committee on Energy 

and Commerce and the Committee on 

Education and Labor of the House of 

Representatives. The Committee is 

governed by the provisions of the 

Federal Advisory Committee Act, 5 

U.S.C. App. 2. 

II. Charter, General Responsibilities, 

and Composition of the State All Payer 

Claims Databases Advisory Committee 

A. Charter Information and General 

Responsibilities 

On February 17, 2021, the Acting 

Secretary approved the charter 

establishing the Committee. The 

Committee will advise the Secretary 

regarding the standardized reporting 

format for the voluntary reporting by 

group health plans to State All Payer 

Claims Databases. Reporting will 

include medical claims, pharmacy 

claims, dental claims, and eligibility 

and provider files collected from private 


jbell on DSKJLSW7X2PROD with NOTICES